WILDLIFE

Welcome to the Brand page for “WILDLIFE”, which is offered here for Veterinary pharmaceuticals, cafentanil citrate and etorphine hydrochloride, synthetic opiates for immobilization of non-domestic species; melatonin, a hormone to mediate light-induced physiological processes in mammals; naltrexone hydrochloride, a pure opiate antagonist to reverse opiate immobilization of non-domestic species; yohimbine hydrochloride, a specific antagonist to alpha-2 sedation in mammals; xylazine hydrochloride, an alpha-2 agonist for sedation in mammals; and carnidazole, a 5-nitro imidizole for treatment of intestinal protozoal infections in birds;immobilization and capture of non-domestic species for medical, management and treatment procedures, and contract studies involving pharmaceutical and biological response of non-domestic species;.

Its status is currently believed to be active. Its class is unavailable. “WILDLIFE” is believed to be currently owned by “WILDLIFE LABORATORIES INCORPORATED”.


Owner:
WILDLIFE LABORATORIES INCORPORATED
Owner Details
Description:
Veterinary pharmaceuticals, cafentanil citrate and etorphine hydrochloride, synthetic opiates for immobilization of non-domestic species; melatonin, a hormone to mediate light-induced physiological processes in mammals; naltrexone hydrochloride, a pure opiate antagonist to reverse opiate immobilization of non-domestic species; yohimbine hydrochloride, a specific antagonist to alpha-2 sedation in mammals; xylazine hydrochloride, an alpha-2 agonist for sedation in mammals; and carnidazole, a 5-nitro imidizole for treatment of intestinal protozoal infections in birds;immobilization and capture of non-domestic species for medical, management and treatment procedures, and contract studies involving pharmaceutical and biological response of non-domestic species;
Categories: VETERINARY PHARMACEUTICALS